Registration open for Veterinary Biologics Training ProgramJanuary 17, 2018The Institute for International Cooperation in Animal Biologics (IICAB) has opened registration for the Veterinary Biologics Training Program, which will be held May 14-18 in Ames, Iowa. The program provides an overview of the U.S. Department of Agriculture's regulatory process for assuring the purity, safety, potency, and efficacy of veterinary biologics (vaccines, bacterins, antisera, diagnostic kits, and other products of biological origin). During the weeklong program, staff from the Center for Veterinary Biologics (CVB) at the USDA's Animal & Plant Health Inspection Service provides information on the requirements and processes for licensing/registration and testing of veterinary biological products. The inspection and compliance process for production, release, and post-marketing surveillance of veterinary biological products is also covered in both lectures and workshops, IICAB said. Professionals working in the veterinary biologic industry, researchers developing biologics, and regulatory personnel are encouraged to attend to learn about current CVB requirements. More than 2,700 individuals have attended the program since it was launched in 1996, including 750 individuals from 90-plus countries. The program is organized by IICAB and is co-sponsored by CVB and the Iowa State University College of Veterinary Medicine. Individuals interested in an introduction or refresher in the ever-changing field of immunology …
SPONSORED CONTENTFast Itch Relief for Canine PatientsA treatment for allergic and atopic dermatitis, given just once a day. Visibly improves itch fast. + Learn More Now
Synthetic Genomics, Ceva partner to develop livestock vaccinesNovember 1, 2017 Synthetic Genomics Inc. announced that it has partnered with Ceva Santé Animale to utilize Synthetic Genomics' next-generation synthetic RNA replicon platform to develop vaccines for livestock. Synthetic Genomics' RNA replicons are programed to deliver genetic instructions to a body's own cells to unleash a powerful immune response against a specific disease, the company said. These RNA replicons carry the genetic code for a self-replication engine as well as antigens that signal for an immune response. The self-amplifying, RNA-based vaccine triggers rapid and immediate antigen expression within host cells, which induces strong T cell and B cell responses. These fully synthetic vaccines have lower dose requirements and simplified manufacturing compared to traditional vaccine approaches, according to the announcement. "We have made tremendous progress to date in programming RNA to develop next-generation vaccines that are multigenic, tunable and, most importantly, scalable for commercially competitive markets such as animal health," said Synthetic Genomics CEO Dr. Oliver Fetzer. "This partnership with Ceva, a leader in animal health, highlights the promise in deploying our synthetic biology capabilities to build RNA systems capable of improving global health in a variety of ways." Financial terms of the agreement were not …
The Immunity Challenge: Vaccines and petsJune 22, 2017Back in the day, dog and cat vaccines were cut and dry, and all pets were vaccinated annually, except perhaps for very old or sick animals. Today, the subject is much more fluid, as more information comes to light regarding duration of immunity, potential negative outcomes from vaccinating too often and adverse vaccine events.
Chinese vaccine lab to move into KC Animal Health CorridorJune 1, 2017KC Animal Health Corridor of Kansas City, Mo., will soon be getting some new neighbors in its new K-State Office Park Phase II building. That’s because Jinyu Bio-technology Co., Ltd. (also known as Jinyu Corp), has announced will open a vaccine research lab and office in the new building in 2018.
New feline core vaccine available from BIVIAugust 18, 2016Boehringer Ingelheim Vetmedica Inc. has released a reduced-volume core vaccine for cats. The nonadjuvanted Ultra Hybrid FVRCP is administered in a 0.5 mL subcutaneous dose to protect against feline herpesvirus, calicivirus infection and distemper in cats at least 8 weeks old.
